Primary Pediatric Psychopharmacology Course Information Given (medication cards, GLAD-PC, T-MAY)
Atypical Antipsychotics: Optimal Dosing/Titration Strategies for Children and Adolescents
http://www.thereachinstitute.org/images/Atypical_Antipsychotics.pdf
Medications for Depression and Anxiety
http://www.thereachinstitute.org/images/3_Meds_Dep_and_Anxiety__Blue_Handout.pdf
Mood Stabilizers in Children and Adolescents
http://www.thereachinstitute.org/images/Mood_Stabilizers.pdf
FDA Approved Medications for ADHD
http://www.thereachinstitute.org/images/4_FDA_ADHD031414_Salmon.pdf
Guidelines for Adolescent Depression in Primary Care (GLAD-PC) Toolkit
The GLAD-PC Toolkit helps primary care providers to put the GLAD-PC guidelines into effect. This toolkit was developed with the input of experts from the areas of adolescent depression, primary care behavioral medicine, parent and family advocacy, guideline development, and quality improvement.
Whenever possible, we have adapted or borrowed generously (and with permission) from those pioneers who had already developed such materials for their own populations and settings. We especially want to thank our partners in depression care improvement from the Texas State Department of Health Services, Columbia University’s Treatment Guidelines Project, Intermountain Health Care, American Medical Association, Western Psychiatric Institute and Clinic, the National Alliance for the Mentally Ill, the Depression & Bipolar Support Alliance, and many others too numerous to mention who have shared time, expertise, and toolkit content.
On behalf the GLAD-PC Steering Committee, organization liaison representatives, and the many expert clinicians who contributed to this process to improve adolescent depression management in primary care, we thank you for your service and efforts for depressed teens.
Download it here: http://gladpc.org/
Treatment of Maladaptive Aggression in Youth (T-MAY) Guidelines Toolkit
The T-MAY Toolkit, intended for both primary care and specialty mental health prescribers, is a concise reference guide designed to aid clinicians in their implementation of the T-MAY guideline. Successful implementation of the T-MAY guidelines ultimately relies on physician expertise and discretion. The T-MAY Toolkit is not intended to undermine or replace clinical judgment.
Psychotropic agents, particularly second-generation antipsychotics and mood stabilizers, are increasingly prescribed to youth on an outpatient basis for the treatment of overt aggression, a symptom that may have multiple causes. These large scale shifts in treatment practices have occurred despite potentially troubling side-effects and a lack of supportive empirical evidence. With the increase in the prescription of psychotropic agents outside of FDA-approved indications, concerns have been raised over treatment decision making, appropriate use of alternative therapies, long-term management, safety of multiple drug regimens, and successful parental engagement and education. Given its indistinct etiology and variability in frequency and severity of symptoms, as well as the presence of overlapping comorbidities, treating and managing aggression is generally difficult and complex.
To address this clinical need and improve outcomes for children and adolescents with maladaptive aggression, a steering committee was established to spearhead a consensus development and quality improvement initiative for clinicians treating such children and adolescents. Through the collaboration of the Resource for Advancing Children’s Health (REACH) Institute, the Center for Education and Research on Mental Health Therapeutics (CERTs) at Rutgers University, Columbia University/New York State Psychiatric Institute, and participating national experts in the fields of policy, research, advocacy and child and adolescent psychiatry, the Treatment of Maladaptive Aggression in Youth (T -MAY) guidelines were developed.
Download it here: http://www.thereachinstitute.org/images/pdfs/T-MAY-final.pdf
